Cetuximab (Erbitux) targets the epidermal growth factor receptor (EGFR) found overexpressed in several Targeted Cancer Therapies including colorectal https://timessquarereporter.com/health/targeted-cancer-therapies-understanding-the-novel-approach-to-fighting-cancer